These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30071687)

  • 1. Development of a Novel Q-body Using an In Vivo Site-Specific Unnatural Amino Acid Incorporation System.
    Kurumida Y; Hayashi N
    Sensors (Basel); 2018 Aug; 18(8):. PubMed ID: 30071687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Quenchbodies by protein transamination reaction.
    Dong J; Jeong HJ; Ueda H
    J Biosci Bioeng; 2016 Jul; 122(1):125-30. PubMed ID: 26811222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef.
    Lucchiari-Hartz M; Lindo V; Hitziger N; Gaedicke S; Saveanu L; van Endert PM; Greer F; Eichmann K; Niedermann G
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7755-60. PubMed ID: 12810958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding.
    Couillin I; Connan F; Culmann-Penciolelli B; Gomard E; Guillet JG; Choppin J
    Eur J Immunol; 1995 Mar; 25(3):728-32. PubMed ID: 7705402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the HIV Nef protein mimic the MHC?
    Hobohm U; Sander C
    FEBS Lett; 1993 Nov; 333(3):211-3. PubMed ID: 8224180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large fragments of nef-protein and gp110 envelope glycoprotein from HIV-1. Synthesis, CD analysis and immunoreactivity.
    Sabatier JM; Fontan G; Loret E; Mabrouk K; Rochat H; Gluckman JC; Montagnier L; Granier C; Bahraoui E; Van Rietschoten J
    Int J Pept Protein Res; 1990 Jan; 35(1):63-72. PubMed ID: 2182558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Price DA; Goulder PJ; Klenerman P; Sewell AK; Easterbrook PJ; Troop M; Bangham CR; Phillips RE
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1890-5. PubMed ID: 9050875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection.
    Gombert FO; Blecha W; Tähtinen M; Ranki A; Pfeifer S; Tröger W; Braun R; Müller-Lantzsch N; Jung G; Rübsamen-Waigmann H
    Virology; 1990 Jun; 176(2):458-66. PubMed ID: 1693246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for making a superior Quenchbody to proteins: effect of the fluorophore position.
    Jeong HJ; Ueda H
    Sensors (Basel); 2014 Jul; 14(7):13285-97. PubMed ID: 25057138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity.
    Welker R; Harris M; Cardel B; Kräusslich HG
    J Virol; 1998 Nov; 72(11):8833-40. PubMed ID: 9765428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
    J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a fluvoxamine detection system using a Quenchbody, a novel fluorescent biosensor.
    Sasao A; Takaki M; Jeong HJ; Yonemitsu K; Ohtsu Y; Tsutsumi H; Furukawa S; Morioka H; Ueda H; Nishitani Y
    Drug Test Anal; 2019 Apr; 11(4):601-609. PubMed ID: 30328685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covariability of selected amino acid positions for HIV type 1 subtypes C and B.
    Gilbert PB; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1016-30. PubMed ID: 16379605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.
    Koenig S; Fuerst TR; Wood LV; Woods RM; Suzich JA; Jones GM; de la Cruz VF; Davey RT; Venkatesan S; Moss B
    J Immunol; 1990 Jul; 145(1):127-35. PubMed ID: 1694201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.
    Giese SI; Woerz I; Homann S; Tibroni N; Geyer M; Fackler OT
    Virology; 2006 Nov; 355(2):175-91. PubMed ID: 16916529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PM Q-probe: A fluorescent binding protein that converts many antibodies to a fluorescent biosensor.
    Dong J; Miyake C; Yasuda T; Oyama H; Morita I; Tsukahara T; Takahashi M; Jeong HJ; Kitaguchi T; Kobayashi N; Ueda H
    Biosens Bioelectron; 2020 Oct; 165():112425. PubMed ID: 32729542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An amino-terminal amino acid affects the electrophoretic mobility of the HIV-1 nef protein.
    Obaru K; DeClue JE; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):308-12. PubMed ID: 1740757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice.
    Liang X; Fu TM; Xie H; Emini EA; Shiver JW
    Vaccine; 2002 Sep; 20(27-28):3413-21. PubMed ID: 12213412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.